Progen Pharmaceuticals Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Jacksonville FL United States (1982)
Status: Acquired by TBG Diagnostics (2016)

Organization Overview

First Clinical Trial
2004
NCT00073892
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree